DCF — ENCORE MEDICAL CENTER
Enterprise Value: $-46.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-46.6M
Enterprise Value
$-15.7M
PV of Cash Flows
$-30.9M
PV of Terminal Value
$-49.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $57.4M | $-2.4M | -4.0% | $-4.8M | $-4.4M |
| Year 2 | $59.1M | $-1.9M | -3.0% | $-4.4M | $-3.6M |
| Year 3 | $60.9M | $-1.3M | -2.0% | $-3.9M | $-2.9M |
| Year 4 | $62.7M | $-1.0M | -2.0% | $-3.7M | $-2.5M |
| Year 5 | $64.6M | $-0.9M | -1.0% | $-3.6M | $-2.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-46.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$55.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04654390637181152
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5